Chicken cathelicidin-2 (CATH-2) reduced inflammatory cytokines and blocked NLRP3 inflammasome activation during avian E. coli infection by disrupting lysosomal function through the NF-κB/NLRP3/MAPK pathway.
3 inflammatory pathways blockedCATH-2 simultaneously inhibited NF-κB, MAPK, and NLRP3 inflammasome activation through a single mechanism: lysosomal disruption
What the researchers found
CATH-2 reduced IL-1β, IL-6, IL-1α, and IL-12 production during APEC infection by inhibiting NLRP3 inflammasome activation, NF-κB and MAPK signaling, and disrupting lysosomal function. Restoring lysosomal acidification reversed CATH-2's anti-inflammatory effects.
Why it matters
Understanding how antimicrobial peptides control inflammation — not just kill bacteria — opens new therapeutic strategies. CATH-2's ability to simultaneously block three inflammatory pathways through lysosomal disruption reveals a sophisticated immune regulation mechanism shared across species.
The numbers in context
CATH-2 reduced IL-1β, IL-6, IL-1α, and IL-12 production. Suppressed NF-κB, NLRP3, and MAPK pathway activation.
How the study worked
Murine peritoneal macrophages primed with CATH-2 and infected with avian pathogenic E. coli. Measured cytokine production, caspase-1 activation, ASC speck formation, NF-κB/MAPK pathway activation, cathepsin B expression, and lysosomal acidification. ML-SA1 rescue experiment confirmed lysosomal mechanism.
Who was studied
Murine peritoneal macrophages infected with avian pathogenic E. coli
What this study cannot tell us
In vitro study using murine macrophages and avian E. coli — the clinical relevance to human infections is unclear. The lysosomal disruption mechanism could have off-target effects in whole organisms. Only one type of immune cell was studied.
How to read the evidence
Preliminary evidence from in vitro macrophage experiments. The mechanism is well-characterized through multiple complementary assays including a rescue experiment.
When this study was published
Published in 2024; adds mechanistic detail to the growing understanding of cathelicidin immune functions.
The bigger picture
Cathelicidins are found across many species, and understanding their anti-inflammatory mechanisms in one organism often reveals principles applicable to human medicine. The NLRP3 inflammasome is a major drug target for conditions from gout to Alzheimer's, and natural peptides that block it could inspire new therapeutics.
Questions still open
- Does CATH-2's lysosomal disruption mechanism apply to human cathelicidin LL-37 as well?
- Could CATH-2-derived peptides be developed as anti-inflammatory therapeutics for inflammasome-driven diseases?
- What are the consequences of CATH-2's lysosomal disruption on overall immune cell function beyond inflammation?
Common questions
What is the NLRP3 inflammasome and why does blocking it matter?
Could this chicken peptide be used in human medicine?
Read the original research
Antimicrobial Peptide CATH-2 Attenuates Avian Pathogenic E. coli-Induced Inflammatory Response via NF-κB/NLRP3/MAPK Pathway and Lysosomal Dysfunction in Macrophages.
International journal of molecular sciences, 25(23)
Citation
Xu, Yating; Xu, Liuyi; Zhang, Tingting; Tian, Hongliang; Lu, Yi; Jiang, Sha; Cao, Xuefeng; Li, Zhiwei; Hu, Xiaoxiang; Fang, Rendong; Peng, Lianci. (2024). Antimicrobial Peptide CATH-2 Attenuates Avian Pathogenic E. coli-Induced Inflammatory Response via NF-κB/NLRP3/MAPK Pathway and Lysosomal Dysfunction in Macrophages.. International journal of molecular sciences, 25(23). https://doi.org/10.3390/ijms252312572